179 related articles for article (PubMed ID: 7756063)
41. Hemodynamic, anti-ischemic, and neurohumoral effects of slow-release isosorbide-5-mononitrate in patients with coronary artery disease after short- and long-term therapy.
Mitrovic V; Gessner C; Hain P; Müller KD; Schlepper M
Clin Cardiol; 1991 Mar; 14(3):209-18. PubMed ID: 1672843
[TBL] [Abstract][Full Text] [Related]
42. Effects of chronic nitrate therapy on left-ventricular volume in patients with heart failure secondary to coronary disease already treated with captopril: a withdrawal study.
Wieshammer S; Hetzel M; Hetzel J; Henze E; Hombach V
Cardiology; 2001; 95(2):61-5. PubMed ID: 11423708
[TBL] [Abstract][Full Text] [Related]
43. Effects of nicorandil on cardiac sympathetic nerve activity after reperfusion therapy in patients with first anterior acute myocardial infarction.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):322-8. PubMed ID: 15791442
[TBL] [Abstract][Full Text] [Related]
44. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
Ishikawa K; Kanamasa K; Ogawa I; Takenaka T; Naito T; Kamata N; Yamamoto T; Nakai S; Hama J; Oyaizu M; Kimura A; Yamamoto K; Aso N; Arai M; Yabushita H; Katori Y
Jpn Circ J; 1996 Oct; 60(10):779-88. PubMed ID: 8933241
[TBL] [Abstract][Full Text] [Related]
45. [The use of oral and intravenous isosorbide mononitrate (5-MNi) in the acute phase of myocardial infarction].
Rezende M
Rev Port Cardiol; 1993 Mar; 12 Suppl 1():I35-8. PubMed ID: 8499118
[TBL] [Abstract][Full Text] [Related]
46. Relation between ST segment elevation during dobutamine stress test and myocardial viability after a recent myocardial infarction.
Elhendy A; Cornel JH; Roelandt JR; van Domburg RT; Geleijnse MI; Nierop PR; Bax JJ; Sciarra A; Ibrahim MM; el-Refaee M; el-Said GM; Fioretti PM
Heart; 1997 Feb; 77(2):115-21. PubMed ID: 9068392
[TBL] [Abstract][Full Text] [Related]
47. An evaluation of the effects of isosorbide 5-mononitrate in patients with angina on effort using dynamic electrocardiography and echocardiography.
Novo S; Nardi E; Alaimo G; Centineo G; Licata G; Strano A
Cardiology; 1987; 74 Suppl 1():20-8. PubMed ID: 3300974
[TBL] [Abstract][Full Text] [Related]
48. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
[TBL] [Abstract][Full Text] [Related]
49. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.
Kitakaze M; Asakura M; Kim J; Shintani Y; Asanuma H; Hamasaki T; Seguchi O; Myoishi M; Minamino T; Ohara T; Nagai Y; Nanto S; Watanabe K; Fukuzawa S; Hirayama A; Nakamura N; Kimura K; Fujii K; Ishihara M; Saito Y; Tomoike H; Kitamura S;
Lancet; 2007 Oct; 370(9597):1483-93. PubMed ID: 17964349
[TBL] [Abstract][Full Text] [Related]
50. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
[TBL] [Abstract][Full Text] [Related]
51. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
[TBL] [Abstract][Full Text] [Related]
52. Circadian investigation of interval therapy with isosorbide dinitrate in coronary heart disease.
Wortmann A; Bachmann K; Meinhold M
Eur Heart J; 1988 Jan; 9 Suppl A():119-24. PubMed ID: 3409908
[TBL] [Abstract][Full Text] [Related]
53. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
Gunasekara NS; Noble S
Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
[TBL] [Abstract][Full Text] [Related]
54. Dose-effect relationship amongst three different sustained-release forms of isosorbide 5-mononitrate in patients with coronary artery disease.
Kenedi P; Gathmann-Lewik U
Cardiology; 1987; 74 Suppl 1():29-33. PubMed ID: 3300975
[TBL] [Abstract][Full Text] [Related]
55. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
56. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
Kumagae H; Koiwaya Y; Tanaka K
Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
[TBL] [Abstract][Full Text] [Related]
57. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
[TBL] [Abstract][Full Text] [Related]
58. Somatostatin plus isosorbide 5-mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled clinical trial.
Junquera F; López-Talavera JC; Mearin F; Saperas E; Videla S; Armengol JR; Esteban R; Malagelada JR
Gut; 2000 Jan; 46(1):127-32. PubMed ID: 10601068
[TBL] [Abstract][Full Text] [Related]
59. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
60. Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: a randomized study.
Rakowski T; Zalewski J; Legutko J; Bartus S; Rzeszutko L; Dziewierz A; Sorysz D; Bryniarski L; Zmudka K; Kaluza GL; Dubiel JS; Dudek D
Am Heart J; 2007 Mar; 153(3):360-5. PubMed ID: 17307412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
